Trends & Forecasts

Collusion, pollution, and a pricing victory for pharma in California… what’s new in business?

Evidence suggests that price controls could hamper innovation and negatively affect patient health outcomes.

Sitting Down With Steve Turley, Managing Director for the British and Irish Isles, UCB.

A podcast series lets listeners eavesdrop on a conversation between scientists in a bar

What impact will Brexit, a new US President, and a flood of new technologies have on the industry?

Steve Keen talks to us about Trump, China, free trade and globalization

The players and chips are ready, what can poker teach us about the biosimilars business?

Big pharma CEOs should be wary of because orphans are usually better off alone.

Sitting Down With... Carol Lynch, Global Head Biopharmaceuticals, Sandoz.

Genentech’s Cell Culture Biologics Drug Substance Plant 2 in Vacaville, California.